References
- Vassiliaclis S., Athanassakis I. Adsorptive or by pit formation endocytosis of immunoglobulins without loss of function as potential biotherapeutical application. Cancer Biother. Radiopharm. 1996; 11: 259–266
- Athanassakis-Vassiliadis I., Vassiliadis S., Papamatheakis J. Common mechanisms govern the expression of p21ras and class II MHC antigens in the murine placenta. J. Reprod. Immunol. 1992; 21: 149–161
- Athanassakis I. Analysis of the IFN-γ-induced signal transduction pathway in fetal rejection. Med. Inflam. 1995; 4: 209–216
- Klausner R. D., Donaldson J. G., Lippincott-Schwartz J., Brefeldin A. Insights into the control of membrane traffic and organelle structure. J Cell Biol. 1992; 116: 1071–1080
- Ziegler H. K., Unanne E. R. Decrease in macrophage antigen catabolism caused by ammonia and chloroquine is associated with inhibition of antigen presentation to T cells. Proc. Ntl. Acad. Sci. USA 1982; 79: 174–186
- Lorand L., Parameswaran K. N., Stenberg P., Tong Y. S., Velasco P. T., Jonsson N. A., Mikiver L., Moses P. Specificity of guinea pig liver transglutaminase for amine substrates. Biochemistry 1979; 18: 1756–1765
- Davies P. J., Cornwell M. M., Johnson J. D., Reggianini A., Myers M., Murtaugh M. P. Studies on the effects of dansylcadaverine and related compounds on receptor-mediated endocytosis in cultured cells. Diabetes Care 1984; 7(Suppl. 1)35–41
- Peters P. J., Neefjes J. J., Oorschot V., Ploegh H. L., Geuze H. J. Segregation of MHC class II molecules from MHC class I molecules in the Golgi complex for transport to lysosomal comparments. Nature 1991; 349: 669–676
- Rich D. H., Bernatowicz M. S., Agarwal N. S., Kawai M., Salituro F. G., Schmidt P. G. Inhibition of aspartic proteases by pepstatin and 3-methylstatine derivatives of pepstatin. Evidence for collected-substrate enzyme inhibition. Biochemistry 1985; 24: 3165–3173
- Schoellmann C., Shaw E. Direct evidence for the presence of histidine in the active center of chymotrypsin. Biochemistry 1963; 2: 252–255
- Segal D. M., Powers J. C., Cohen G. H., Davies D. R., Wilcox P. E. Substrate binding site in bovine chymotrypsin A-gamma. A crystallographic study using peptide chloromethyl ketones as sitespecific inhibitors. Biochemistry 1971; 10: 3728–3738
- Athanassakis I., Aifantis Y., Ranella A., Vassiliadis S. Production of embryotoxic IgG antibodies during IFN-γ treatment of pregnant mice. Amer. J. Reprod. Immunol. 1996; 36: 111–117
- Athanassakis-Vassiliadis I., Thanos D., Papamatheakis J. Induction of class II major histocompatibility complex antigens in murine placenta by 5-azacytidine and interferon-γ involves different cell populations. Eur. J. Immunol. 1989; 19: 2341–2348
- Athanassakis I., Iconomidou B. Cytokine production in the serum and spleen of mice from day 6 to 14 of gestation. Dev. Immunol. 1996; 4: 247–255
- Bugelski P. J., Kaplan J. M., Hart T. K., Miller J., Laydon J. T., Lee J. C., Dreyer G. B., Kirsh R. Effect of a human immunodeficiency virus protease inhibitor on human monocyte function. AIDS Res. Hum. Retroviruses 1992; 8: 1951–1958
- Moyle G., Gazzard B. Current knowledge and future prospects for the use of HIV protease inhibitors. Drugs 1996; 51: 701–712
- Murray H. W. Interferon-gamma, the activated macrophage, and host defense against microbial challenge. Ann. Intern Med. 1988; 108: 595–608